Portfolio of Technologies: Novel Compositions and Improvements to CRISPR/Cas12 Systems
Ability to detect small molecules and proteins Sensitivity of nucleic acid detection PAMless detection of nucleic acids RNA detection without reverse transcription, thermal stability and new functions Novel isothermal Cas12 based amplificaiton methods that allow for one-pot point of care applications, including diagnosis of cancer and infectious disease